Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TP53 |
Variant | V157fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | TP53 V157fs results in a change in the amino acid sequence of the Tp53 protein beginning at aa 157 of 393, likely resulting in premature truncation of the functional protein (UniProt.org). V157fs results in loss of Tp53 protein expression, and increased proliferation, migration, and invasion in cultured cells (PMID: 33987408), and therefore, is predicted to lead to a loss of Tp53 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
TP53 mutant TP53 exon5 TP53 V157fs TP53 mutant TP53 inact mut TP53 V157fs |
Transcript | NM_000546.6 |
gDNA | chr17:g.(7675143_7675144) |
cDNA | c.(469_468) |
Protein | p.V157fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001126112.3 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_000546.6 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001407262.1 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001126114 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001126114.3 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001407264.1 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001126114.2 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001407270.1 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001126113 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001126113.3 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001407268.1 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_000546 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_000546.5 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001126112.2 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001126113.2 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001126112 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
NM_001407266.1 | chr17:g.(7675143_7675144) | c.(469_468) | p.V157fs | RefSeq | GRCh38/hg38 |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|